Literature DB >> 16981028

Feasibility analysis of loop colostomy closure in patients under local anesthesia.

Rone Antônio Alves de Abreu1, Manlio B Speranzini, Luís C Fernandes, Delcio Matos.   

Abstract

PURPOSE: To verify prospectively the practicability of performing loop colostomy closure under local anesthesia and sedation.
METHODS: In this study, 21 patients underwent this operation. Lidocaine 2% and bupivacaine 0.5% were utilized. Pain was evaluated during the operation, on the first postoperative day and at hospital discharge. Intraoperative events, postoperative complications and the acceptability of this procedure were analyzed.
RESULTS: The mean duration of the operation was 133 minutes (range: 85 to 290 minutes). The mean postoperative hospitalization was four days (range: one to twelve days). No patients died. Complications occurred in two patients (9.4%): abdominal wall hematoma and operative wound infection. With regard to pain severity, scores of less than or equal to three were indicated in the intraoperative evaluation by 80% of the patients (17/21) and on the first postoperative day by 85% (18/21). At hospital discharge, 95.2% of the patients (20/21) said they were in favor of the local anesthesia technique.
CONCLUSION: Loop colostomy closure under local anesthesia and sedation is feasible, safe and acceptable to patients.

Entities:  

Mesh:

Year:  2006        PMID: 16981028     DOI: 10.1590/s0102-86502006000500002

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  2 in total

1.  The effect of peri-stomal infiltration with bupivacaine/epinephrine on post-operative pain, nausea and ease of surgery in reversal of loop ileostomies.

Authors:  Kawan Shalli; C Watson; Lynn McCaffer; David Clough; Vimty Muir; Angus Macdonald
Journal:  Int J Colorectal Dis       Date:  2009-08-14       Impact factor: 2.571

2.  Is Radical Bowel Cancer Resection Under Local Anaesthesia and Sedation Feasible?

Authors:  J Sebastian; H Sran; D Marzouk
Journal:  Indian J Surg       Date:  2015-05-21       Impact factor: 0.656

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.